Ubidecarenone 585 views0 applications

Australian Approved Name (AAN): Ubidecarenone

Common name/s and synonyms: Co-Enzyme Q10; Ubidecarenone anhydrous

Molecular formula: C59H90O4

Molecular weight: 863.34

Maximum daily dose: 300mg

Warnings and restrictions: When used as an excipient, the route of administration must be topical.  Only for use in topical medicines for dermal application and not to be included in medicines intended for use in the eye.  When used as an excipient, the concentration in the medicine must be no more than 0.05%.

When used in combination with Ubiquinol-10, the maximum recommended daily dose must provide no more than 300mg of ubiquinol-10 and ubidecarenone combined.

The medicine requires the following warning statement on the medicine label:
WARF – Do not take while on warfarin therapy without medical advice.

Allowable purpose of the ingredient: Active. Excipient

TGA reference: International Non-Proprietary Name

Apply for this resource
Share this resource

Advanced Wellness Regulatory Solutions are a team of highly skilled professionals who specialise in providing timely and reliable regulatory and research & development advice.



While we take all measures to ensure that the information provided on this site is accurate, before relying on the material in any important matter, users should carefully evaluate its accuracy, completeness and relevance for their purposes, and should obtain any appropriate professional advice relevant to their particular circumstances.


Want to stay up to date with the latest industry changes and updates? Signup to our newsletter below.